Organized crime has moved into selling counterfeit and compromised prescription drugs in Europe, exploiting the mishmash of customs laws and weak points in some border protection. Those weaknesses allowed the "Mafia" to get fake manifests, use suspect wholesalers, and sell counterfeits of Roche's Herceptin and other cancer drugs across Europe.
A Turkish man who admitted to smuggling counterfeit cancer drugs to the U.S. labeled as gifts or documents has been sentenced to 27 months in federal prison.
Counterfeiters managed to get fakes of some of Roche's ($RHHBY) top-selling cancer drugs, including Herceptin and MabThera/Rituxan, into the European market this summer. This, among other issues, has motivated Roche's Genentech to have specialty distributors handle these recently conterfeited drugs, as well as Avastin. This decision has outraged some hospitals.
Counterfeiters in Europe are displaying a fondness for mimicking high-priced Roche cancer drugs. For the second time in 5 months, authorities there have uncovered fakes, and the two cases appear not to be connected.
Authorities from 8 European Union countries, backed by Europol and Eurojust, have arrested a dozen suspects and seized more than €10 million worth of counterfeit drugs, mostly fakes of erectile dysfunction drugs that an organized crime group was selling online. The raid, announced Monday, came after an investigation that lasted nearly two years.
Researchers at the University of Michigan have developed an anti-counterfeiting technology based on clear plastic labels that reveal an image when someone breathes on them.
One of two men from Turkey that federal authorities accused of smuggling counterfeit cancer drugs to the U.S. labeled as gifts or documents has admitted he is guilty.
China has established new rules to protect its pharma supply from counterfeiting and allow for faster recalls, but the government shortened the timeframe for meeting them: forcing drumakers and contractors to scramble to catch up.
The World Health Organization says counterfeit and substandard antibiotics are getting into the global supply chain and creating resistance to treatments while fueling the emergence of so-called superbugs.
Germany is implementing a system that allows the authenticity of drugs to be checked at the pharmacy level to protect against counterfeits.